X-153905590-A-C
Position:
Variant summary
Our verdict is Benign. Variant got -15 ACMG points: 0P and 15B. BP4_StrongBP6_ModerateBP7BS1BS2
The NM_000054.7(AVPR2):āc.84A>Cā(p.Pro28=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000996 in 1,205,301 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 4 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Genomes: š 0.000018 ( 0 hom., 1 hem., cov: 26)
Exomes š: 0.0000092 ( 0 hom. 3 hem. )
Consequence
AVPR2
NM_000054.7 synonymous
NM_000054.7 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0380
Genes affected
AVPR2 (HGNC:897): (arginine vasopressin receptor 2) This gene encodes the vasopressin receptor, type 2, also known as the V2 receptor, which belongs to the seven-transmembrane-domain G protein-coupled receptor (GPCR) superfamily, and couples to Gs thus stimulating adenylate cyclase. The subfamily that includes the V2 receptor, the V1a and V1b vasopressin receptors, the oxytocin receptor, and isotocin and mesotocin receptors in non-mammals, is well conserved, though several members signal via other G proteins. All bind similar cyclic nonapeptide hormones. The V2 receptor is expressed in the kidney tubule, predominantly in the distal convoluted tubule and collecting ducts, where its primary property is to respond to the pituitary hormone arginine vasopressin (AVP) by stimulating mechanisms that concentrate the urine and maintain water homeostasis in the organism. When the function of this gene is lost, the disease Nephrogenic Diabetes Insipidus (NDI) results. The V2 receptor is also expressed outside the kidney although its tissue localization is uncertain. When these 'extrarenal receptors' are stimulated by infusion of a V2 selective agonist (dDAVP), a variety of clotting factors are released into the bloodstream. The physiologic importance of this property is not known - its absence does not appear to be detrimental in NDI patients. The gene expression has also been described in fetal lung tissue and lung cancer associated with alternative splicing. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -15 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.0).
BP6
Variant X-153905590-A-C is Benign according to our data. Variant chrX-153905590-A-C is described in ClinVar as [Likely_benign]. Clinvar id is 759980.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=-0.038 with no splicing effect.
BS1
Variant frequency is greater than expected in population eas. gnomad4 allele frequency = 0.0000177 (2/112830) while in subpopulation EAS AF= 0.000561 (2/3563). AF 95% confidence interval is 0.0000988. There are 0 homozygotes in gnomad4. There are 1 alleles in male gnomad4 subpopulation. Median coverage is 26. This position pass quality control queck.
BS2
High Hemizygotes in GnomAdExome4 at 3 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AVPR2 | NM_000054.7 | c.84A>C | p.Pro28= | synonymous_variant | 3/4 | ENST00000646375.2 | NP_000045.1 | |
AVPR2 | NM_001146151.3 | c.84A>C | p.Pro28= | synonymous_variant | 3/3 | NP_001139623.1 | ||
AVPR2 | NR_027419.2 | n.465+420A>C | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AVPR2 | ENST00000646375.2 | c.84A>C | p.Pro28= | synonymous_variant | 3/4 | NM_000054.7 | ENSP00000496396 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000177 AC: 2AN: 112830Hom.: 0 Cov.: 26 AF XY: 0.0000286 AC XY: 1AN XY: 35020
GnomAD3 genomes
AF:
AC:
2
AN:
112830
Hom.:
Cov.:
26
AF XY:
AC XY:
1
AN XY:
35020
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000494 AC: 8AN: 162052Hom.: 0 AF XY: 0.0000184 AC XY: 1AN XY: 54224
GnomAD3 exomes
AF:
AC:
8
AN:
162052
Hom.:
AF XY:
AC XY:
1
AN XY:
54224
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000915 AC: 10AN: 1092471Hom.: 0 Cov.: 35 AF XY: 0.00000835 AC XY: 3AN XY: 359241
GnomAD4 exome
AF:
AC:
10
AN:
1092471
Hom.:
Cov.:
35
AF XY:
AC XY:
3
AN XY:
359241
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000177 AC: 2AN: 112830Hom.: 0 Cov.: 26 AF XY: 0.0000286 AC XY: 1AN XY: 35020
GnomAD4 genome
AF:
AC:
2
AN:
112830
Hom.:
Cov.:
26
AF XY:
AC XY:
1
AN XY:
35020
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at